Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump
Omeprazole is the first agent in a new therapeutic advance class the proton or acid pump inhibitors which represents a significant therapeutic advance in the treatment of acid related diseases. Omeprazole reduces gastric acid secretion at its source – the acid pump of the parietal cell, thereby offe...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1989-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1989/463572 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|